Uncategorized

There are three (general) concepts related to the extent of antimicrobial resistance MDR, XDR, and PDR.  Based on the definitions of these concepts, it seems from a subtype/subset point of view they create a logical hierarchy.  At present, they are positioned as discrete non-overlapping categories, which I believe is how microbiologists view them.  I'd like your input.  There is one question on the slide (in the document) and a sort of follow-up question: Which hierarchy diagram position

The existing content treats the relationship between resistance and the factors responsible for resistance in two different ways.  The file associated with this discussion is a PDF of the notes pages for slides 5, 6 and 7 of the presentation given during the May 2019 OIDM PG meeting.   During the meeting, we learned from Farzaneh Ashrafi that existing editorial policy indicates that production of a resistance principle by a bacteria DOES NOT EQUATE with clinical resistance among bacteria. 

The introduction to this discussion lists a number of questions related to preferences for term styles and hierarchy content.  The file associated with this discussion is the notes view of slide #4 from a presentation given during the May 2019 OIDM meeting.  There are three major questions I've associated with this slide and I'd like your help determining the answers. Should the drug names in these terms conform to names in the substance hierarchy? Should the "main" term, some combinati

I'm trying to scope out some work relating to virus and wanting to confirm what the preferred reference source is. I was looking at O http://www.ontobee.org/search?ontology=NCIT&keywords=Nairoviridae&submit=Search+termsntoBee/OBO work (specifically http://www.ontobee.org/ontology/NCIT?iri=http://purl.obolibrary.org/obo/NCIT_C14283 http://www.ontobee.org/ontology/NCIT?iri=http://purl.obolibrary.org/obo/NCIT_C14283) The ICTV work (https://talk.ictvonline.org/taxonomy/ https://talk.ictvonli

I just want to ask about concept like 702938004 |Klebsiella pneumoniae or Klebsiella oxytoca (finding)| I notice that since 2014 these sort of things have been modeled as findings (I vaguely recall the discussions at the time). However, this does complicate things for some microbial reports where a more specific identification isn't available/possible. And these sort of groupers are as clinically useful, and as specific as is required. (To me at least) It seems on par with saying 127535004

Even a cursory review of the antimicrobial resistant content in the organism hierarchy suggests that it could be used to facilitate flagging of antimicrobial resistant organism isolates for antimicrobials of specific, even dire, concern.  Some editing is in order as described in documents posted for the November 2018 - OIDM Meeting.   What is less clear is how this content might be logically (and automatically) associated with clinical laboratory reports of actual isolates.  Without a use cas

If the premise that 41146007 | Bacterium (organism) duplicates the meaning of 409822003 | Superkingdom Bacteria (organism), then it should be retired.  If this concept class is retired, its first generation descendants will be assigned by transitive closure to the next higher supertype, in this case 409822003 | Superkingdom Bacteria.  The newly edited hierarchy can be divided into roughly into two classifications - one based on so-called "Linnaean" principles (e.g. Phylum Proteobacteria) like

During our last OIDM Web conference, I failed to include an important group of concepts related to antimicrobial resistance. The present discussion is mostly about the fate of a few "odd" organisms but the conversation also has bearing on an eventual need to discuss a proper "fit" for organisms in laboratory results, disorders, etc. meant to convey information about resistance. I'd appreciate any time you could take to review the attached documents (see attachments on drop-down menu for this

Salmonella serovar synchronization between WHO CC and SNOMED CT